Home » UPC decisions » Local Division » LD Munich, July 17, 2026, Order, UPC_CFI_2307/2026

LD Munich, July 17, 2026, Order, UPC_CFI_2307/2026

4 min Reading time

Key takeaways

The Court must balance the applicant’s right to a fast remedy against the respondent’s right to be heard and the panel’s need for adequate preparation time.

The Court found that the respondent group was already aware of the four patents and the allegation of infringement due to ongoing parallel Australian proceedings based on four Autralian patents, which are the Atralian equivalents of the patents asserted in the present proceedings. This reduced the need for extensive preparation time for the UPC proceedings.

The Court rejected the respondent’s argument that time without CMS access should be added to the deadline, clarifying the date was fixed intentionally to manage the schedule.

The applicant consented to an extension only if the hearing date was unchanged. Since the Court found this impossible, it concluded no valid consent was given.

Division

Local Division Munich

UPC number

UPC_CFI_2307/2026

Type of proceedings

Proceedings for provisional measures

Parties

Applicant: OXFORD NANOPORE TECHNOLOGIES PLC
Respondents: MGI TECH GmbH, MGI TECH CO., LIMITED, BGI HANGZHOU CYCLONESEQ TECHNOLOGY CO., LTD, SHENZHEN BGI GENOMICS CO., LTD

Patent(s)

EP 2 422 198 B1, EP 2 715 343 B1, EO 2 964 779 B1, EP 3 097 210 B2

Jurisdictions

UPC, Liechtenstein, Switzerland, Ireland, UK

Body of legislation / Rules

R. 9.3(a) RoP, R. 209.1 RoP


Was the article helpful?


Categories


Tags

Stay in the loop

Never miss a beat by subscribing to the email newsletter. Please see our Privacy Policy.

* = Required field